Literature DB >> 12192544

An update on thyroid surgery.

O Gimm1, M Brauckhoff, P N Thanh, C Sekulla, H Dralle.   

Abstract

Surgery has been the treatment of choice for many disorders of the thyroid gland, both benign and malignant, for many decades. However, surgery has not been invariable but has continued to change in accordance with research results. In benign cases, surgery has generally evolved to be as organ preserving as possible. In several instances, however, a more radical extent of resection seems justified in order to ensure that the risk of recurrence is as low as possible. For instance, total thyroidectomy may be beneficial in patients with endemic multinodular goitre or young patients with Graves' disease and accompanying cold nodules or high levels of autoantibodies. Several tools, e.g. magnifying glasses, bipolar coagulation forceps and neuromonitoring, are available to identify and preserve the recurrent laryngeal nerve and the parathyroid glands, hence keeping the morbidity at a low level. Most recently, minimally invasive surgery has been successfully used in treating both benign and malignant disorders of the thyroid gland. In the case of malignant disorders, minimally invasive surgery may become an attractive alternative to open surgery if a limited surgical extent is justified, e.g. in patients with micro-PTC (papillary thyroid carcinoma, diameter less than 1 cm). Whether a limited surgical approach is also justified in other cases, e.g. in any patient with intrathyroidal PTC or patients with micro-FTC (follicular thyroid carcinoma), remains to be shown and is the subject of ongoing investigations. One of the most intriguing recent discoveries is the identification of genotype-phenotype correlations in patients with hereditary medullary thyroid carcinoma. In these patients, the timing and extent of surgery may depend not only on the patient's age and serum levels of the tumour marker calcitonin but also on the specific germline RET proto-oncogene mutation. Surgery will certainly continue to play an important role in the treatment of thyroid diseases and may be increasingly based on individual findings instead of general recommendations.

Entities:  

Mesh:

Year:  2002        PMID: 12192544     DOI: 10.1007/s00259-002-0913-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  7 in total

1.  Prospective validation study of Cernea classification for predicting EMG alterations of the external branch of the superior laryngeal nerve.

Authors:  Gianlorenzo Dionigi; Hoon Yub Kim; Gregory W Randolph; Che-Wei Wu; Hui Sun; Xiaoli Liu; Marcin Barczynski; Feng-Yu Chiang
Journal:  Surg Today       Date:  2015-09-11       Impact factor: 2.549

Review 2.  Narrative review of proving the causal link of recurrent laryngeal nerve injury and thyroidectomy: a medico legal appraisal.

Authors:  Patrizia Gualniera; Serena Scurria; Cristina Mondello; Alessio Asmundo; Daniela Sapienza; Dionigi Gianlorenzo
Journal:  Gland Surg       Date:  2020-10

3.  Retrospective evaluation of the incidental finding of 403 papillary thyroid microcarcinomas in 2466 patients undergoing thyroid surgery for presumed benign thyroid disease.

Authors:  Nikola Slijepcevic; Vladan Zivaljevic; Jelena Marinkovic; Sandra Sipetic; Aleksandar Diklic; Ivan Paunovic
Journal:  BMC Cancer       Date:  2015-04-30       Impact factor: 4.430

Review 4.  Intraoperative neuromonitoring of the external branch of the superior laryngeal nerve during thyroidectomy: the need for evidence-based data and perioperative technical/technological standardization.

Authors:  Alberto Mangano; Georgios D Lianos; Luigi Boni; Hoon Yub Kim; Dimitrios H Roukos; Gianlorenzo Dionigi
Journal:  ScientificWorldJournal       Date:  2014-11-24

Review 5.  A Review of Methods for the Preservation of Laryngeal Nerves During Thyroidectomy.

Authors:  Mehmet Uludağ; Mert Tanal; Adnan İşgör
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2018-06-18

6.  Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?

Authors:  Zhen Wu; Lin Han; Wenlei Li; Wei Wang; Liqaing Chen; Yumin Yao; Yongkun Wang
Journal:  Cancer Med       Date:  2021-01-29       Impact factor: 4.452

7.  With High-Risk Factors, Total Thyroidectomy is Preferred for Thyroid Cancer.

Authors:  Lin Han; Wenlei Li; Yingxue Li; Wenjuan Wen; Yumin Yao; Yongkun Wang
Journal:  Cancer Manag Res       Date:  2020-05-20       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.